Confident Catabasis Takes Positives From Failed Duchenne Trial Into Phase III

 
• By Kevin Grogan
  
Next Level
Catabasis is putting its DMD drug into Phase III trials • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D